Medical Properties Trust, Inc. (NYSE:MPW) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Monday.

A number of other analysts also recently issued reports on the company. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $16.00 target price on shares of Medical Properties Trust in a research report on Monday, July 24th. Jefferies Group LLC raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Tuesday, July 4th. BidaskClub raised Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Deutsche Bank AG raised their price target on Medical Properties Trust from $13.50 to $15.00 and gave the company a “buy” rating in a research note on Tuesday, July 4th. Finally, Stifel Nicolaus restated a “hold” rating and issued a $13.00 price target on shares of Medical Properties Trust in a research note on Friday, July 28th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $14.10.

Medical Properties Trust (NYSE MPW) opened at 13.18 on Monday. Medical Properties Trust has a one year low of $11.54 and a one year high of $15.04. The stock’s 50 day moving average price is $13.00 and its 200-day moving average price is $13.07. The firm has a market cap of $4.61 billion, a price-to-earnings ratio of 16.11 and a beta of 0.88.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 EPS for the quarter, hitting the consensus estimate of $0.32. Medical Properties Trust had a net margin of 42.25% and a return on equity of 7.54%. The firm had revenue of $166.80 million for the quarter, compared to analysts’ expectations of $163.08 million. During the same period in the previous year, the firm posted $0.32 EPS. The company’s revenue for the quarter was up 32.1% on a year-over-year basis. Analysts forecast that Medical Properties Trust will post $0.86 earnings per share for the current year.

WARNING: This piece was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/04/valuengine-upgrades-medical-properties-trust-inc-mpw-to-buy.html.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BB&T Securities LLC boosted its stake in shares of Medical Properties Trust by 0.3% during the 2nd quarter. BB&T Securities LLC now owns 31,541 shares of the real estate investment trust’s stock worth $405,000 after acquiring an additional 102 shares during the period. Creative Planning increased its holdings in shares of Medical Properties Trust by 0.7% during the 2nd quarter. Creative Planning now owns 27,554 shares of the real estate investment trust’s stock worth $355,000 after acquiring an additional 185 shares during the last quarter. Southeast Asset Advisors Inc. increased its holdings in shares of Medical Properties Trust by 1.7% during the 2nd quarter. Southeast Asset Advisors Inc. now owns 12,824 shares of the real estate investment trust’s stock worth $165,000 after acquiring an additional 216 shares during the last quarter. TD Asset Management Inc. increased its holdings in shares of Medical Properties Trust by 0.9% during the 2nd quarter. TD Asset Management Inc. now owns 26,676 shares of the real estate investment trust’s stock worth $343,000 after acquiring an additional 233 shares during the last quarter. Finally, Capstone Asset Management Co. raised its stake in Medical Properties Trust by 1.0% in the 2nd quarter. Capstone Asset Management Co. now owns 29,830 shares of the real estate investment trust’s stock valued at $384,000 after acquiring an additional 290 shares during the period. 83.69% of the stock is owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Stock Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related stocks with our FREE daily email newsletter.